View Item 

Show simple item record

Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base

dc.contributor.authorCoghill, Anna E.
dc.contributor.authorHan, Xuesong
dc.contributor.authorSuneja, Gita
dc.contributor.authorLin, Chun Chieh
dc.contributor.authorJemal, Ahmedin
dc.contributor.authorShiels, Meredith S.
dc.date.accessioned2019-08-09T17:14:08Z
dc.date.availableWITHHELD_13_MONTHS
dc.date.available2019-08-09T17:14:08Z
dc.date.issued2019-08-15
dc.identifier.citationCoghill, Anna E.; Han, Xuesong; Suneja, Gita; Lin, Chun Chieh; Jemal, Ahmedin; Shiels, Meredith S. (2019). "Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base." Cancer (16): 2868-2876.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/150550
dc.publisherWiley Periodicals, Inc.
dc.subject.otherhealth insurance and mortality
dc.subject.otherHIV and cancer
dc.subject.otherNational Cancer Data Base
dc.subject.othercancer stage
dc.subject.othercancer patient mortality
dc.titleAdvanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/150550/1/cncr32158.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/150550/2/cncr32158_am.pdf
dc.identifier.doi10.1002/cncr.32158
dc.identifier.sourceCancer
dc.identifier.citedreferenceZucchetto A, Virdone S, Taborelli M, et al. Non–AIDS‐defining cancer mortality: emerging patterns in the late HAART era. J Acquir Immune Defic Syndr. 2016; 73: 190 ‐ 196.
dc.identifier.citedreferenceGrulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta‐analysis. Lancet. 2007; 370: 59 ‐ 67.
dc.identifier.citedreferenceHernandez‐Ramirez RU, Shiels MS, Dubrow R, Engels EA. Cancer risk in HIV‐infected people in the USA from 1996 to 2012: a population‐based, registry‐linkage study. Lancet HIV. 2017; 4: e495 ‐ e504.
dc.identifier.citedreferenceEngels EA, Biggar RJ, Hall HI, et al. Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer. 2008; 123: 187 ‐ 194.
dc.identifier.citedreferenceBertisch B, Franceschi S, Lise M, et al; Swiss HIV Cohort Study Investigators. Risk factors for anal cancer in persons infected with HIV: a nested case‐control study in the Swiss HIV Cohort Study. Am J Epidemiol. 2013; 178: 877 ‐ 884.
dc.identifier.citedreferenceEngels EA, Pfeiffer RM, Goedert JJ, et al; HIV/AIDS Cancer Match Study. Trends in cancer risk among people with AIDS in the United States 1980‐2002. AIDS. 2006; 20: 1645 ‐ 1654.
dc.identifier.citedreferenceEltom MA, Jemal A, Mbulaiteye SM, Devesa SS, Biggar RJ. Trends in Kaposi’s sarcoma and non‐Hodgkin’s lymphoma incidence in the United States from 1973 through 1998. J Natl Cancer Inst. 2002; 94: 1204 ‐ 1210.
dc.identifier.citedreferenceJacobson LP, Yamashita TE, Detels R, et al. Impact of potent antiretroviral therapy on the incidence of Kaposi’s sarcoma and non‐Hodgkin’s lymphomas among HIV‐1–infected individuals. Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 1999; 21 ( suppl 1 ): S34 ‐ S41.
dc.identifier.citedreferenceRobbins HA, Shiels MS, Pfeiffer RM, Engels EA. Epidemiologic contributions to recent cancer trends among HIV‐infected people in the United States. AIDS. 2014; 28: 881 ‐ 890.
dc.identifier.citedreferenceCoghill AE, Engels EA, Schymura MJ, Mahale P, Shiels MS. Risk of breast, prostate, and colorectal cancer diagnoses among HIV‐infected individuals in the United States. J Natl Cancer Inst. 2018; 110: 959 ‐ 966.
dc.identifier.citedreferenceShiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV‐infected population in the United States. J Natl Cancer Inst. 2011; 103: 753 ‐ 762.
dc.identifier.citedreferenceShiels MS, Islam JY, Rosenberg PS, Hall HI, Jacobson E, Engels EA. Projected cancer incidence rates and burden of incident cancer cases in HIV‐infected adults in the United States through 2030. Ann Intern Med. 2018; 168: 866 ‐ 873.
dc.identifier.citedreferenceShiels MS, Copeland G, Goodman MT, et al. Cancer stage at diagnosis in patients infected with the human immunodeficiency virus and transplant recipients. Cancer. 2015; 121: 2063 ‐ 2071.
dc.identifier.citedreferenceCoghill AE, Shiels MS, Suneja G, Engels EA. Elevated cancer‐specific mortality among HIV‐infected patients in the United States. J Clin Oncol. 2015; 33: 2376 ‐ 2383.
dc.identifier.citedreferenceSuneja G, Boyer M, Yehia BR, et al. Cancer treatment in patients with HIV infection and non–AIDS‐defining cancers: a survey of US oncologists. J Oncol Pract. 2015; 11: e380 ‐ e387.
dc.identifier.citedreferenceSuneja G, Shiels MS, Angulo R, et al. Cancer treatment disparities in HIV‐infected individuals in the United States. J Clin Oncol. 2014; 32: 2344 ‐ 2350.
dc.identifier.citedreferenceAmerican College of Surgeons Commission on Cancer. About cancer program categories. https://www.facs.org/quality-programs/cancer/coc/apply/categories. Accessed February 11, 2019.
dc.identifier.citedreferencePalefsky JM. Screening to prevent anal cancer: current thinking and future directions. Cancer Cytopathol. 2015; 123: 509 ‐ 510.
dc.identifier.citedreferenceChao C, Xu L, Abrams D, et al. Survival of non‐Hodgkin lymphoma patients with and without HIV infection in the era of combined antiretroviral therapy. AIDS. 2010; 24: 1765 ‐ 1770.
dc.identifier.citedreferenceMarcus JL, Chao C, Leyden WA, et al. Survival among HIV‐infected and HIV‐uninfected individuals with common non–AIDS‐defining cancers. Cancer Epidemiol Biomarkers Prev. 2015; 24: 1167 ‐ 1173.
dc.identifier.citedreferenceSigel K, Crothers K, Dubrow R, et al. Prognosis in HIV‐infected patients with non‐small cell lung cancer. Br J Cancer. 2013; 109: 1974 ‐ 1980.
dc.identifier.citedreferenceD’Arcy ME, Coghill AE, Lynch CF, et al. Survival after a cancer diagnosis among solid organ transplant recipients in the United States. Cancer. 2019; 125: 933 ‐ 942.
dc.identifier.citedreferenceHodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010; 363: 711 ‐ 723.
dc.identifier.citedreferenceRobert C, Long GV, Brady B, et al. Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med. 2015; 372: 320 ‐ 330.
dc.identifier.citedreferencePostow MA, Callahan MK, Wolchok JD. Immune checkpoint blockade in cancer therapy. J Clin Oncol. 2015; 33: 1974 ‐ 1982.
dc.identifier.citedreferenceFerreira MP, Coghill AE, Chaves CB, et al. Outcomes of cervical cancer among HIV‐infected and HIV‐uninfected women treated at the Brazilian National Institute of Cancer. AIDS. 2017; 31: 523 ‐ 531.
dc.identifier.citedreferenceFrisch M, Biggar RJ, Engels EA, Goedert JJ; AIDS‐Cancer Match Registry Study Group. Association of cancer with AIDS‐related immunosuppression in adults. JAMA. 2001; 285: 1736 ‐ 1745.
dc.identifier.citedreferenceBedimo RJ, McGinnis KA, Dunlap M, Rodriguez‐Barradas MC, Justice AC. Incidence of non–AIDS‐defining malignancies in HIV‐infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr. 2009; 52: 203 ‐ 208.
dc.identifier.citedreferenceChaturvedi AK, Madeleine MM, Biggar RJ, Engels EA. Risk of human papillomavirus–associated cancers among persons with AIDS. J Natl Cancer Inst. 2009; 101: 1120 ‐ 1130.
dc.identifier.citedreferenceBruyand M, Thiébaut R, Lawson‐Ayayi S, et al; Groupe d’Epidemiologie Clinique du SIDA en Aquitaine (GECSA). Role of uncontrolled HIV RNA level and immunodeficiency in the occurrence of malignancy in HIV‐infected patients during the combination antiretroviral therapy era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort. Clin Infect Dis. 2009; 49: 1109 ‐ 1116.
dc.identifier.citedreferenceSilverberg MJ, Chao C, Leyden WA, et al. HIV infection, immunodeficiency, viral replication, and the risk of cancer. Cancer Epidemiol Biomarkers Prev. 2011; 20: 2551 ‐ 2559.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr32158.pdf
Size:
209.0KB
Format:
PDF
View/Open
Name:
cncr32158_am.pdf
Size:
230.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.